| (Values in U.S. Thousands) | Jan, 2026 | Oct, 2025 | Jul, 2025 | Apr, 2025 | Jan, 2025 |
| Sales | 1,024,100 | 1,065,100 | 1,060,300 | 1,002,300 | 964,700 |
| Sales Growth | -3.85% | +0.45% | +5.79% | +3.90% | -5.27% |
| Net Income | 130,800 | 84,600 | 98,300 | 87,700 | 104,300 |
| Net Income Growth | +54.61% | -13.94% | +12.09% | -15.92% | -11.23% |
Cooper Companies (COO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.'CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Fiscal Year End Date: 10/31